Article
For its upcoming Directions in Pharmacy® conference in Nashville, Tennessee, Pharmacy Times Continuing EducationTM is partnering with Lilly USA, LLC to present “An Insulin Monotherapy Option for Patients on High Doses of Insulin.”
For its upcoming Directions in Pharmacy® conference in Nashville, Tennessee, Pharmacy Times will feature a product theater titled “An insulin monotherapy option for patients on high doses of insulin, sponsored by Lilly USA, LLC.”
The program, set to take place at noon on April 14, 2018, in the Renaissance Nashville Hotel’s Belmont Room, will be led by Jonathan Marquess, PharmD, CDE, FAPhA, the president and CEO of the Institute for Wellness and Education.
The program is about a concentrated human insulin indicated to improve glycemic control for specific patients. Discuss a hypothetical patient case study as a means to identify appropriate candidates, review the efficacy and safety profile, and go over how to initiate and titrate patients on this insulin monotherapy regimen.
Those interested in registering for the Directions in Pharmacy® conference in Nashville can register at pharmacytimes.org/dip2018.